Elevance Health, Inc.: financial statements

ELVNYSEHealthcare · Hospital & Medical Service Plans

Price

$400.84

November 18, 2026Market cap $88.5B

What Ploutos Investor adds for Elevance Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Financial statements

Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.

2023–2025 fiscal years

Click a line to see it on the chart.

Revenue

+7.8% a year over 2 years

Line202320242025Average a year
Revenue $171B$177B$199B+7.8%
Cost of revenue $17.3B$19.8B$21.2B+10.7%
Gross profit $154B$157B$178B+7.5%
Operating income $8.5B$7.9B$7.2B-8.0%
Net income $6.0B$6.0B$5.7B-2.8%
Earnings per share $25.22$25.68$25.21-0.0%
Earnings per share, basic $25.38$25.81$25.28-0.2%
Margins
Gross margin 89.9%88.8%89.4%
Operating margin 5.0%4.4%3.6%
Net margin 3.5%3.4%2.8%

Financial statements

ELV's revenue, profits and cash flows from 2009 to 2022, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

By segment

Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.

  • 2023: Health Benefits $149B, Carelon Rx $33.8B, Carelon Services $14.1B
Segment2023Share 2023
Health Benefits$149B76%
Carelon Rx$33.8B17%
Carelon Services$14.1B7.2%

By segment

ELV's revenue by segment from 2013 to 2022, 10 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Left out: 2024, 2025. In those filings two breakdowns were tagged at once (product lines beside regions), so the lines add up to well over the company's revenue.

From the XBRL of 17 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.

Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.

Debt and obligations

What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.

$2.7B Due within 2 years$660M Leases152% Pensions funded

When the debt falls due

Dec 31, 2025

Due within 2 years

$2.7B

Principal of loans and bonds falling due, from the annual report dated December 31, 2025, without leases and interest. The filing

  • 2026: $1.1B
  • 2027: $1.6B

Leases

Dec 31, 2025

Operating leases

$660M

Finance leases

–

The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt. The filing

Pension plans

Dec 31, 2025

Defined-benefit pensions

152%funded

Surplus $621M.

The obligation is the present value of the pensions employees have already earned, at December 31, 2025. A deficit is the company's to fill with contributions. The filing

ObligationPlan assets

Goodwill by segment

Dec 31, 2025

Total goodwill

$28.3B

  • Health Benefits$22.5B79%

Goodwill is what the company paid in acquisitions above the value of what it bought, at December 31, 2025. If an acquisition earns less, the goodwill is impaired and earnings fall. The filing

$28.3BTotal goodwill

From the statutory to the effective tax rate, 2025

Dec 31, 2025

Statutory rate

21.0%

Effective rate

15.6%

-5.4 pts

The company paid 15.6% in tax on its profit, 5.4 points below the US federal rate (21.0%). Below, the reasons it gives.

Statutory rate

21.0%

Non-deductible expenses

-2.6 pts

Difference the filing does not itemize

-2.8 pts

Effective rate

15.6%

One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing

Earnings quality

How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.

Taxes: deferred and paid

The deferred part was -26.6% of the tax charge in the year to Dec 31, 2025. The rows show the last 3 years.

Cash taxes paid were 103.0% of the current tax charge in the year to Dec 31, 2025.

Deferred share, year to Dec 31, 2025-$279M of $1.0B
-26.6%
Deferred share, year to Dec 31, 2024-$374M of $1.9B
-19.4%
Deferred share, year to Dec 31, 2023-$602M of $1.7B
-34.9%
$1.4B paid, $1.3B current
103.0%

When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.

For an insurer only the tax part applies: receivables, inventory and an operating margin do not describe its business.

A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.

The full analysis

What do Elevance Health's filings show?

These are Elevance Health's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ELV's financials

Didn't find what you were looking for?

Ask us
How much revenue did ELV have in 2025?

Elevance Health had revenue of $199B and net income of $5.7B in fiscal 2025, a net margin of 2.8%.

How much debt does ELV have?

On December 31, 2025 Elevance Health had total assets of $121B, debt of $31.9B and shareholders' equity of $43.9B.

How much free cash flow does ELV have?

In fiscal 2025 Elevance Health had cash from operations of $4.3B and spent $1.1B on capital expenditure, leaving $3.2B of free cash flow.

Where are the figures from?

From Elevance Health, Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.